201 related articles for article (PubMed ID: 10823277)
1. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway.
Sheu JR; Hsiao G; Lee C; Chang W; Lee LW; Su CH; Lin CH
Thromb Res; 2000 Aug; 99(3):249-58. PubMed ID: 10942791
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets.
Sheu JR; Hung WC; Kan YC; Lee YM; Yen MH
Br J Haematol; 1998 Oct; 103(1):29-38. PubMed ID: 9792285
[TBL] [Abstract][Full Text] [Related]
4. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
8. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G
Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.
Chou DS; Chan CH; Hsiao G; Shen MY; Tsai YJ; Chen TF; Sheu JR
J Biomed Sci; 2006 May; 13(3):333-43. PubMed ID: 16283430
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
15. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity.
Park WH; Kim KS; Kim KH; Kim DS; Kim CH
Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
[TBL] [Abstract][Full Text] [Related]
17. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation.
Sheu JR; Hsiao G; Shen MY; Chou CY; Lin CH; Chen TF; Chou DS
Platelets; 2003 May; 14(3):189-96. PubMed ID: 12850843
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
